How many institutions held BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 in Q2 2022?

90 institutional investors reported BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 for Q2 2022. Use the holders table for investor-level position and value details.

BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)

Q: What does CUSIP 09075P105 represent in this 13F holders report?

CUSIP 09075P105 is the security identifier for BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 used to aggregate holder disclosures.

CUSIP: 09075P105

Q2 2022 13F Holders as of 30 Jun 2022

Security type / class: Equity / Common Stock, par value $0.001
Total 13F shares: 12,674,614
Total 13F value: $167,321,205
Share change: -397,687
Put/Call ratio: 86%
SEC-reported price per share: $13.20
Number of holders: 90
Value change: -$8,492,233
Number of buys: 45
Number of sells: 42
Shares outstanding: 27,093,277

Security key

09075P105

Report period

Q2 2022

Institutions

Top holders

BTAI full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 BioXcel Therapeutics, Inc. SEC filings BioXcel Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 09075P105

Newer quarter: Q3 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BioXcel Holdings, Inc.

Disclosed value leader

BioXcel Holdings, Inc.

Comparable rows

0/15

Latest evidence

31 Mar 2022

3/4/5 13F Highest disclosed value: $187,088,358 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BioXcel Holdings, Inc. has the largest disclosed position value at $187.09M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BioXcel Holdings, Inc.'s linked filing trail.

Disclosed position value Top 5

BioXcel Holdings, Inc. $187.09M

BioXcel LLC $187.09M

FMR LLC $87.77M

Artemis Investment Management LLP $29.86M

STATE STREET CORP $29.29M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BioXcel Holdings, Inc.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$187,088,358 8,546,750 shares	—	25 Jun 2021
BioXcel LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$187,088,358 8,546,750 shares	—	25 Jun 2021
FMR LLC	13F Company 13F	— denominator unverified	$87,766,000 4,197,324 shares	—	31 Mar 2022
Artemis Investment Management LLP	13F Company 13F	— denominator unverified	$29,855,000 1,428,228 shares	—	31 Mar 2022
STATE STREET CORP	13F Company 13F	— denominator unverified	$29,290,000 1,400,753 shares	—	31 Mar 2022
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$26,787,000 1,280,979 shares	—	31 Mar 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

12,674,614

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q3 2025 Across Filers

Q3 2025 holders

Q2 2022 holders

Holder diff

Investor	Q3 2025 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q3 2025 value	Q2 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend